Table 1.

Demographic, clinical, and serum biochemical characteristics of patients admitted to the intensive care unit with severe coronavirus disease 2019^a and treated with glucocorticoids

Patient	Age	Sex	SAPS 2	Crb	Ureab	Minimum Na	Maximum K	Pre-treatment			Post-treatment
								DHEA	Cortisol	Ald	Average K	Average Na	Urea
	(years)			(mg/dL)	(mg/dL)	(mEq/L)	(mEq/L)	(ng/mL)	(µg/dL)	(ng/dL)	(mEq/L)	(mEq/L)	(mg/dL)
1	70	M	88	13.48	332	134	7.4	ND	ND	ND	3.4	155	98
2	69	M	89	11.12	228	133	7.0	ND	ND	ND	3.9	146	50
3	65	M	71	10.52	145	127	7.9	ND	25.8	21.4	3.4	136	38
4	60	F	82	6.5	298	130	7.3	ND	ND	ND	4.1	138	100
5	65	M	80	4.63	99	127	7.5	ND	ND	ND	3.5	143	83
6	73	M	75	5.16	131	131	6.0	151	28.4	7.9	3.3	150	48
7	68	M	80	3.29	229	133	7.8	ND	ND	ND	3.7	145	86
8	76	M	49	0.92	314	132	6.8	ND	ND	ND	3	145	48
9	59	M	82	10.92	158	130	7.6	365	33	40.5	4	147	92
10	66	F	ND	3.2	134	128	6.7	93	12.1	15.5	3.6	141	67
11	73	M	93	1.88	113	132	6.3	ND	ND	7.8	3.9	144	88
12	76	F	79	0.8	26	126	7.3	ND	30.5	41.5	3.3	148	20
13	78	M	59	2.5	78	130	7.1	ND	14.8	ND	4.2	140	30

SAPS 2 Simplified Acute Physiology Score 2, Cr creatinine, DHEA dehydroepiandrosterone, Ald aldosterone, ND no data

^aAll of the patients tested positive for infection with severe acute respiratory syndrome coronavirus 2, on high-throughput sequencing real-time reverse transcriptase–polymerase chain reaction assay of nasal-pharyngeal/tracheal swab specimens or on an antibody test

^bAt admission